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Fatty acid acylation of membrane proteins was studied on human erythrocytes by measuring incorporation of [‘HJpalmitate at different specific 
radioactivities. A 55 kDa polypeptide within the band 4.5 region was the main acceptor protein for acylation by fatty acids (palmitate, stearate, 
oleate), while other polypeptides (80,65,48,30 kDa) incorporated [‘Hlpalmitate slowly, in substoichiometric amounts. Integral membrane proteins 
were preferentially fatty acid acylated. Skeletal membrane proteins were, however, poorly labeled. Neither purified ankyrin nor band 4.1 protein 
were fatty acid acylated in human erythrocytes. On the other hand, label associated with high molecular weight skeletal proteins resisted low and 
high ionic strength extractions, and was extracted selectively by uran along with a small subpopulation of spectrin which was also tightly associated 
with the membrane. 
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1. INTRODUCTION 
Proteins from eukaryotic cells can be modified by 
transfer of fatty acid groups (for review see [l]). 
Myristoylation by protein N-myristoyl-CoA-trans- 
ferase is a cotranslational modification of amino- 
terminal glycine residues [11. This capacity is lost during 
maturation of reticulocytes to erythrocytes. Mature red 
cells retain evidently an enzyme catalyzed acylation of 
proteins with long chain fatty acids, which was detected 
in most cells: it requires ATP and acyl-coenzyme A and 
involves cysteine and serine (or threonine) residues on 
acceptor membrane proteins [ 11. Marinetti and Cattieu 
(21 have first reported on incorporation of different 
types of radiolabeled fatty acids into human erythro- 
cyte membrane proteins. Label was associated with the 
spectrin/ankyrin region, band 3 protein, and mainly 
with a polypeptide between bands 4.2 and 5 by analysis 
on SDS-polyacrylamide gels. Band 3 protein and band 
4.1 were also palmitoylated in rat erythrocytes [3]. 
More recently Staufenbiel and Lazarides reported on 
palmitoylation of the peripheral membrane protein 
ankyrin in embryonic chicken and rabbit erythrocytes 
[4,5]. These authors and others [6] showed evidence for 
ester- or thioester bonds between fatty acids and mem- 
brane proteins by demonstrating their release by 
hydroxylamine. 
proteins. Fatty acid acylation of peripheral proteins 
could condition and/or regulate the association of these 
proteins with the plasma membrane. Thus, knowledge 
of the acylated proteins among the cytoskeletal proteins 
is required to understand membrane architecture and 
membrane dynamics. So far acylated polypeptides were 
assigned by studying incorporation of label into electro- 
phoretically spread polypeptides of isolated mem- 
branes. In this report we studied the extent of fatty acid 
incorporation into membranes and its recovery in ex- 
tracts and purified cytoskeletal proteins. 
2. EXPERIMENTAL PROCEDURES 
2.1. Preparation and labeling of erythrocytes 
These results suggest hat posttranslational fatty acid 
acylation occurs on integral and even some peripheral 
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Fresh human blood (0, Rh +) was collected in a heparin substitute, 
liquemin, and was provided by the Swiss Red Cross. Erythrocytes 
were freed from leucocytes by filtration through cellulose [7] and 
washed three times with PBS-glucose (10 mM phosphate, 140 mM 
NaCl, 5 mM KCl, 0.5 mM EDTA, 5 mM glucose, pH 7.4). Red cells 
were pretreated with fatty acid-free BSA (Sigma A6003) to lower the 
endogenous content of free fatty acids in their membrane pools. Cells 
were treated twice for 15 min at room temperature with 10 vols of in- 
cubation buffer (without pyruvate and coenzyme A) containing 0.2% 
BSA and finally washed once with incubation buffer for fatty acid 
labeling: 40 mM imidazole, 90 mM NaCl, 5 mM KCl, 5 mM MgC12, 
15 mM D-glucose, 0.5 mM EGTA, 30 mM sucrose, 5 mM sodium 
pyruvate, 5 mM Coenzyme A, 50 mg PMSF/ml and 200 U penicillin 
0 (320 mOsm, pH 7.6). [9,10 (n)-‘Hlpalmitic acid (54 Ci/mmol, 
Amersham) was dissolved in ethanol and diluted with incubation buf- 
fer. For labeling 100 ~1 of BSA-treated red cells were suspended to a 
hematocrite of 0.1 with 200 ,uCi [3H]palmitate/ml and incubated for 
up to 12 h at 37°C. Incubation was stopped by addition of ice-cold 
PBS-glucose. Extracellular [3H]palmitate was removed by two washes 
of the cells with buffer containing 0.2% BSA instead of palmitate. In 
some experiments the following labeled fatty acids were used instead 
of palmitate: [3H]oleic acid (5 Ci/mmol), [‘Hlarachidonic acid (202 
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Ci/mmol) and [%]stearic acid (56 mCi/mmol) obtained from Amer- 
sham. For preparative purposes 15 ml BSA-treated erythrocytes were 
labeled with [‘Hlpalmitate (200 &i/ml) at a hematocrite of 0.3. 
2.2 Extraction of peripheral membrane proteins 
Erythrocyte membranes were prepared from labeled cells m 
hypotonic phosphate as previously described [8], including one wash 
of ghosts with isotonic solutions to remove glyceraldehyde-3-phos- 
phate dehydrogenase (band 6) [9]. Low ionic strength-extractable 
spectrin and actin were obtained according to ref. (lo], after washing 
membranes with extraction buffer in the cold. Ankyrin was extracted 
with a buffer containing 1 M KC1 [9]. This extraction procedure coex- 
tracted protein band 4.1. The pellets (KCl-stripped IOV) were washed 
once with hemolysis buffer containing 1 mM dithiothreitol. The 
residual amount of spectrin retained in KCl-stripped IOV [ll] was 
selectively extracted by 5 M urea in the presence of 5 mM NaCl, 2.5 
mM phosphate (pH 7.4), and is characterized elsewhere (Mariani and 
Lutz, unpublished and Mariani, PhD Thesis, ETH 1989). Ankyrin 
and protein band 4.1 were partially purified from the high ionic 
strength extracts of IOV from [3H]palmitate labeled cells. The two 
proteins were purified by ion exchange chromatography as previously 
described [ 121. 
2.3. Separation and detection of radiolabeled polypeptides 
Analytical scale: erythrocyte membranes were prepared by 
hemolysis of 100,ul of radiolabeled cells in Eppendorf tubes. Suspen- 
sions were centrifuged with an Eppendorf desk centrifuge for 2 min 
at 4°C. Membranes and extracted fractions were supplemented with 
1% SDS and 5 mM N-ethylmaleimide prior to freezing. Samples were 
analyzed by SDS polyacrylamide gel electrophoresis (8% acrylamide) 
on a slightly modified Neville system [ 131, in which ankyrin migrates 
partially within spectrin band 2, essentially as described for the Laem- 
mli system [14]. Samples were reduced for 30 min at 37°C and 
alkylated with N-ethylmaleimide before electrophoresis [ 151. 
Coomassie blue stained gels were soaked with PPO (2O’JJo) in DMSO 
and dried gels exposed to Kodak X-100 film at - 70°C [16]. Two iden- 
tical gels were run in parallel, one was stained and used for 
fluorography, from the other gel pieces were excised for determining 
incorporated radioactivities. The gel pieces were treated with 0.75 ml 
Amersham-NCS-solubilizer/water (9: 1, v/v) for 24 h at room 
temperature. After neutralization with acetic acid the samples were 
kept overnight before measuring radioactivity by liquid scintillation 
counting. The amount of incorporated palmitate was calculated from 
three different specific radioactivities of [3H]palmitate in the incuba- 
tion mixtures with erythrocytes and from the radioactivity incor- 
porated into separated polypeptide bands from SDS polyacrylamide 
gels. The counting efficiency for [“Hlpalmitate was 44%. The protein 
content in membrane preparations was determined by measuring ab- 
sorbance at 280 nm in samples olubilized with 1% SDS using BSA as 
a reference. 
3. RESULTS 
3.1. Palmitoylated polypeptides of human erythrocyte 
membranes 
Human erythrocytes were washed with fatty acid-free 
BSA to reduce the unknown pool of endogenous free 
fatty acids before incorporation with [‘Hlpalmitate. 
Erythrocytes were incubated with [3H]palmitate at 3 
specific activities and incorporation of label into mem- 
brane proteins was studied by SDS PAGE and fluoro- 
graphy (fig.1). Membranes revealed a set of at least 
8-10 labeled polypeptides. A 55 kDa polypeptide within 
the region of band 4.5 on Coomassie blue stained gels 
and low molecular weight polypeptides at the tracking 
dye were the major substrates for palmitoylation. Other 
306 
heavily labeled polypeptides migrated with apparent 
molecular masses of 80, 65, 48, 40 and 30 kDa, Minor 
labeling was found in the high molecular weight poly- 
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Fig.1. Labeling of membrane polypeptides after incubation of 
erythrocytes with [3H]palmitic acid at different specific activities: a, 
23.8; b, 9.5; c, 2.4 nCi/pmol palmitic acid added. (A) Labeling pat- 
tern (4 h incubation) of membrane polypeptides revealed by 
fluorography (‘H, exposed for 4 days) together with the correspon- 
ding stained gel (CB). The numbers on the right side give the apparent 
molecular masses of the polypeptides in kDa. The polypeptides of 
erythrocyte membranes were numbered l-5 as in 19-121. (B) Incor- 
poration of label into several membrane polypeptides as a function of 
the concentration of [‘Hlpalmitate (12 h incubation). 
Volume 259, number 2 FEBS LETTERS January 1990 
peptides of the sp~trin/ank~in region and in a 140 
kDa polypeptide. 
Incorporation of [3H]palmitate was proportional to 
the concentration of added palmitate at constant total 
radioactivity. The linear dose-response relationship in- 
dicates that the pool of endogenous ubstrates was suc- 
cessfully reduced by the BSA treatment (fig.lB). 
Enhanced palmitoylation of membrane proteins with 
increasing concentrations of palmitate reflects a low af- 
finity of the involved enzyme(s) for the substrate in in- 
tact cells. 
Most of the incorporated palmitate was cleaved from 
electrophoretic~ly separated poly~ptides when gels 
were treated with hydroxylamine at pH 7.0 suggesting 
ester or thioester linkages (not shown). Quantitation of 
incorporated [3H]palmitate revealed even after an in- 
cubation for 12 h a small extent of modification of most 
pol~eptides, except for the 55 kDa protein (table 1). 
Time courses of [3H]pa~itate incorporation display a 
rapid labeling of the 55 kDa polypeptide (fig.2) and of 
the proteolipids (PLP) at the tracking dye (not shown), 
but a retarded labeling of other analyzed polypeptides 
(80 and 40 kDa) (fig.2). The total amount of incor- 
porated palmitate reached only 1.4 nmol p~~tate/ml 
cells within 12 h at a concentration of 37 /.cM of added 
palmitate. 
3.2. Incorporation of different fatty acid substrates 
[14C]Stearic acid which is commercially available at a 
specific activity of Ill000 of that of [3H]palmitate was 
chosen to test whether this saturated fatty acid showed 
the same specificity of labeling as palmitate. It labeled 
identical polypeptides. Double labeling experiments 
Table 1 
Quantitation of palmitate incorporation into human erythrocyte 
membrane proteins 
Relative mass of 
polypeptide (kDa) 
[‘Hlpalmitate 
pmol/mg 
membrane protein 
Palmitate groups 
incorporated/cell 
2401220 2.1 800 
140 4.4 1800 
80 17.4 6800 
6.5 9.0 3500 
55 84.9 33000 
48 21.1 8000 
40 46.1 18000 
30 23.3 9000 
Incorporation of palmitate into ery-throcyte membrane polypeptides 
was determined on intact cells incubated for 12 h at 37°C with 
[3H]palmitate. Incorporated pmol of palmitate were averaged from 
four determinations for each band at a specific radioactivity of 2.4 
nCi/pmol at a concentration of 37 ,A4 of added palmitate (see fig. 1). 
The palmitate groups incorporated per cell were estimated based on 
the membrane protein content per erythrocyte as given in 181 
(6.5 x IO-” mg). For most polypeptides listed the number of copies 
per cell is not known. It is known for dglycophorin 600000 [17], 
which probably corresponds to the 80 kDa polypeptide and for the Rh 
antigen that exists in about 60000 copies per cell [ 181 
2 4 
incubation time ( h ) 
6 
Fig.2. Time course of palmitate incorporation into the three major 
fatty acid acylated polypeptides of human erythrocyte membranes. 
Erythrocytes were incubated with 3.4 #M palmitic acid (23.8 
nCi/pmol). 
further revealed simultaneous incorporation of both 
fatty acids at a ratio of 3/l for palmitate into the 55 
kDa polypeptide (not shown). This indicates a non- 
specific use of substrates by the enzymes catalyzing 
membrane protein acylation. 
unsaturated fatty acids were incorporated into 
erythrocyte membrane proteins to some extent. A time 
course for 13H]oleic acid incorporation into membrane 
polypeptides with about l/10 of the specific radioactivi- 
ty of palmitate yielded less labeling but the same subset 
of radiolabeled proteins. Incorporation of r3H]arachi- 
donic acid was co~iderably lower and was about 3% of 
the palmitate incorporation at comparable specific 
radioactivity (not shown). 
3.3. Palmitate incorporation into extracted skeletal 
membrane proteins 
Ankyrin and band 4.1 appeared to be fatty acid 
acylated in membranes of chicken and rabbit erythro- 
cytes [4,5]. Human erythrocytes incorporated very little 
[‘Hlpalmitate into the spectrin/ankyrin region (fig. 1) 
and the labeled polypeptide with an apparent mass of 80 
kDa did not completely coincide with band 4.1. Thus, 
extracts enriched in spectrin or ankyrin and band 4.1 
protein were studied for their content of f3H]palmitate. 
Low ionic strength extracted spectrin from [3H]palmi- 
toylated erythrocytes was not labeled (fig,3A,a). Some 
label appeared to be associated with coextracted band 
4.1, while most label was localized in a 55 kDa polypep- 
tide and at the tracking dye. Extracts obtained with 1 M 
KC1 from IOV were enriched in ankyrin and band 4.1 
(fig.3A,b). They did neither contain labeled ankyrin 
nor band 4.1, Instead, they revealed label in the 55 kDa 
307 
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HMW{ 4 
4s 
55K 
actin 
ab a b 
ankyrin 
pol~eptide and in low molecular weight ~l~ptides 
at the tracking dye. Separation of ankyrin from band 
4.1. by ion exchange chromatography confirmed the 
findings. No label remained associated with either 
ankyrin or band 4.1 (fig.3B), and label associated with 
the containing 55 kDa protein was diminished. 
Thus, the minor labeling of HMW proteins (fig.1) 
had to be confined to other proteins. Extraction of 
membranes by low and high ionic strength buffers 
yielded KCl-stripped IOV, which yet contained the label 
(fig.4a). Urea (5 M) extraction of KCl-stripped IOV 
liberated selectively a tightly membr~e-bound spectrin 
fraction [ 111 and the minor label associated with HMW 
polypeptides (fig.4c). Most of the incorporated 
palmitate label associated with KCl-stripped IOV re- 
mained, however, membrane-bound after urea extrac- 
tion. The urea-extract contained primarily two polypep- 
tides reminiscent of spectrin bands 1 and 2, since they 
comigrated with spectrin bands 1 and 2, respectively 
(fig.4c). The second band carried t3H]palmitate 
(fig.4c). 
CB 3H 
ankyrin 
4.1 
55K 
a ba b 
Fig.3. Low ionic strength extraetabie spa&in, ankyrin, and band 4.1 
protein are not fatty acid acylated in human erythrocytes. Intact celts 
were incubated for 12 h with [jH]palmitate as outlined. Membranes 
prepared from these cells were extracted with low ionic strength and 
the remaining vesicles with high ionic strength buffers. (A) Extracts 
were analysed on SDS PAGE (CB) and by fluorography [‘HI. a, low- 
ionic strength extract from membranes, containing mainly spectrin 
and actin; b, KCI-extract from IOV, containing primarily ankyrin and 
band 4.1. (B) Ankyrin and band 4. I protein were purified from KCI- 
extracts. Fluorograms of the purified preparations did neither show 
label comigrating with ankyrin, nor with band 4.1. a, purified 
a bc a bc 
Fig.4. Extraction of ankyrin-depleted KCl-stripped IOV by urea. 
Vesicles and extracts were analyzed on SDS-PAGE by staining (CB) 
and by fluorography [‘HI. a, KCI-stripped IOV retained a portion of 
tightly membrane-associated spectrin; b, vesicles obtained after ex- 
traction with urea (5 M); c, urea extract containing predominantly 
polypeptides comigrating with spectrin band 1 and 2 and associated 
ankyrin; b, purified band 4.1 protein. with band 2 labeled palmitate (see arrow). 
4. DISCUSSION 
Incorporation of radiolabeled fatty acids into specific 
membrane polypeptides comprised at least 81000 
palmitate groups/cell (table 1) at high palmitic acid 
concentrations. The majority of proteins that were fatty 
acid-acylated in human erythrocytes are integral mem- 
brane proteins, since inside-out vesicles (IOV) as well as 
CB 3H 
55K 
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KCI-stripped IOV retained the entire set of fatty acid 
acylated polypeptides (fig.4). The main acyl acceptor 
protein is a 55 kDa polypeptide in the band 4.5 region, 
which rapidly incorporated 13H]p~mitate (fig.2), 
[3H]oleate and [14C]stearate {not shown) and contained 
about 40% of the total amount of fatty acids attached 
to membrane proteins. Incorporation of a variety of 
substrates into membrane proteins and competition ex- 
periments suggest a nonspecific use of fatty acids in this 
posttranslation~ acylation/deacylation cycle in human 
red blood cells. The nature and function of the 55 kDa 
polypeptide and of its fatty acid modification is 
unknown. 
Recently one of the fatty acid acylated integral pro- 
teins was identified as the Rh pol~eptide in human 
erythrocyte membranes 161. Its apparent molecular 
weight was 32 kDa, it could be identical with the 30 kDa 
polypeptide described here which remained bound to 
vesicles after extraction of peripheral membrane pro- 
teins. 
No data were reported hitherto about the stoichio- 
metry of palmitate/mol membrane protein. Based on 
the estimated incorporation of palmitate groups (table 
l), and the total number of proteins per cell (where 
known) most of the labeled proteins undergo a sub- 
stoichiometric protein modification by fatty acid acyla- 
tion. In fact, ~3H~p~mitate incorporation into 
peripheral membrane proteins of human erythrocytes 
was minute. The high extent of labeling within the band 
4.1 region (fig.1) was not associated with the skeletal 
protein band 4.1. Extracted and purified band 4.1 pro- 
tein contained no label (fig.3). Thus, label associated 
with the 80 kDa region probably resides in a-glyco- 
phorin 1191, which is known to run as a dimer in the 
band 4.1 region [20], and migrates predominantly as a 
dimer, when samples were denatured at 37°C [21]. 
Ankyrin was clearly not labeled in human erythro- 
cytes. Label associated with high molecular weight 
pol~ptides was neither extracted by low nor by high 
salt solutions and remained bound to KCI-stripped 
IOV. This is in contrast to results reported for em- 
bryonic chicken and rabbit erythrocytes [4,5], where 
goblin [22] (chicken) and ankyrin (rabbits) were ap- 
parently fatty acid acylated in isolated membranes. The 
discrepancy could be due to species differences as far as 
it concerns chicken and human red cells, This is less 
likely for rabbit and human red cells which both contain 
ankyrin. In case of rabbit red cells Staufenbiel assigned 
label associated with high molecular weight proteins on 
fluorograms of SDS PAGE of membranes to ankyrin 
on the basis of analogy rather than following extraction 
and purification of ankyrin 151. 
It was interesting that a [3H]palmitate labeled 
polypeptide in the high molecular weight region resisted 
low and high ionic strength extractions. Particularly its 
resistance to high ionic strength extraction differen- 
tiates this component from ankyrin. Its selective 
solubilization by urea suggests that urea, which can per- 
turb hydrophobic interactions [23], extracted a fatty 
acid acyIated and thus tightly membrane associated 
polypeptide. Its coextraction with spectrin band 1 and 2 
from KCl-stripped IOV can have several reasons: 
released spectrin may originate from right-side-out 
vesicles (ROV) and/or from a tightly membrane- 
associated subpopmation of spectrin [ 11,241. Since low 
ionic strength-extracted spectrin was not fatty acid 
acylated at all, mere entrapment of a fraction of it in 
ROV and its release by urea would not explain the fin- 
dings. Thus, the fatty acid label was either confined to 
a tightly membrane-associated subpopulation of spec- 
trin or, less likely, of ankyrin. If the fatty acid label 
were confined to spectrin band 2, the 800 copies of 
labeled polypeptide (table 1) had to originate exclusive- 
ly from that fraction of spectrin which was not ex- 
tracted by low ionic strength. Since this fraction com- 
prised at the most 8.5% [25] of the total spectrin, 
roughly 10% of the it would have carried the label. 
Conclusive evidence awaits purification and peptide 
analysis of the extracted protein. 
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